Infrastructure for bioinformatics applications in Tanzania: Lessons from the sickle cell programme
Tirzepatide is a dual GLP-1 and GIP receptor agonist, working on two key metabolic pathways to enhance weight loss, reduce appetite, improve satiety, and support blood sugar regulation
Eur J Clin Invest 51(8):e13551 Grobbee DE, Filippatos G, Desai NR, Coats AJS, Pinto F, Rosano GMC, Cleland JGF, Kammerer J, de Arellano AR (2024) Epidemiology and risk factors for hyperkalaemia in heart failure
Available at: Hogan MC, et al
Symptoms and Impact of Drug-Induced Gastroparesis Gastroparesis is characterized by delayed stomach emptying, leading to symptoms such as: Nausea and vomiting Stomach pain and abdominal discomfort Early satiety (feeling full) and being unable to finish meals Bloating and dry heaves Heartburn and loss of appetite For those affected, gastroparesis can disrupt daily life, causing frequent hospital visits, significant medical expenses, and emotional distress
Do not shake swirl gently until fully dissolved